Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
暂无分享,去创建一个
[1] Takayuki Hamano,et al. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011) , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[2] Patrick Royston,et al. Multiple Imputation by Chained Equations (MICE): Implementation in Stata , 2011 .
[3] K. Iseki,et al. Tachycardia as a predictor of poor survival in chronic haemodialysis patients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] T. Hasegawa,et al. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007) , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[5] H. Hirakata,et al. Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008 , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[6] T. Akizawa,et al. Ultrapure Dialysate Influences Serum Myeloperoxidase Levels and Lipid Metabolism , 2009, Blood Purification.
[7] K. Iseki,et al. Bacteriological Qualities of Dialysis Fluid in Japan as of 31 December 2006 , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[8] K. Wakai,et al. Overview of Regular Dialysis Treatment in Japan as of 31 December 2006 , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[9] I. Masakane. Review: Clinical Usefulness of Ultrapure Dialysate— Recent Evidence and Perspectives , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] K. Fushimi,et al. An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2001) 1 , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[11] R. Wolfe,et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.
[12] R. Fischer,et al. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Naoki Matsuhashi,et al. Endotoxin-Free Dialysate Improves Response to Erythropoietin in Hemodialysis Patients , 2002, Nephron.
[14] I. Ichikawa,et al. Embryogenesis of the congenital anomalies of the kidney and the urinary tract. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] C. Wanner,et al. Section IV. Dialysis fluid purity. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] R. Fischer,et al. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] G. Lonnemann. Chronic Inflammation in Hemodialysis: The Role of Contaminated Dialysate , 2000, Blood Purification.
[18] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[19] I Ledebo,et al. Defining the microbiological quality of dialysis fluid. , 1999, Artificial organs.
[20] Y. Berland,et al. Using Ultrapure Water in Hemodialysis Delays Carpal Tunnel Syndrome , 1991, The International journal of artificial organs.
[21] J. Vienken,et al. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes. , 1989, ASAIO transactions.
[22] L. Henderson,et al. Hemodialysis Hypotension: The Interleukin Hypothesis , 1983 .